letrozole has been researched along with Minimal Disease, Residual in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, M | 1 |
| Erdenebaatar, C | 1 |
| Saito, F | 1 |
| Motohara, T | 1 |
| Miyahara, Y | 1 |
| Tashiro, H | 1 |
| Katabuchi, H | 1 |
| Bedard, PL | 1 |
| Singhal, SK | 1 |
| Ignatiadis, M | 1 |
| Bradbury, I | 1 |
| Haibe-Kains, B | 1 |
| Desmedt, C | 1 |
| Loi, S | 1 |
| Evans, DB | 1 |
| Michiels, S | 1 |
| Dixon, JM | 2 |
| Miller, WR | 1 |
| Piccart, MJ | 1 |
| Sotiriou, C | 1 |
| Schaverien, MV | 1 |
| Raine, C | 1 |
| Majdak-Paredes, E | 1 |
3 other studies available for letrozole and Minimal Disease, Residual
| Article | Year |
|---|---|
Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.
Topics: Adult; Aromatase; Aromatase Inhibitors; Bone Density; Endometrial Neoplasms; Endometrial Stromal Tum | 2015 |
Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Pharmacological; Biomarkers, Tumor; Brea | 2011 |
Therapeutic mammaplasty--extending indications and achieving low incomplete excision rates.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; | 2013 |